Impact of Gleason, Stage and Age on Surgery and Radiotherapy in Prostate Cancer Patients in Northern Italy.
[BACKGROUND] The incidence of prostate cancer is increasing due to the aging and early diagnosis.
APA
Mangone L, Marinelli F, et al. (2025). Impact of Gleason, Stage and Age on Surgery and Radiotherapy in Prostate Cancer Patients in Northern Italy.. Clinical genitourinary cancer, 23(4), 102383. https://doi.org/10.1016/j.clgc.2025.102383
MLA
Mangone L, et al.. "Impact of Gleason, Stage and Age on Surgery and Radiotherapy in Prostate Cancer Patients in Northern Italy.." Clinical genitourinary cancer, vol. 23, no. 4, 2025, pp. 102383.
PMID
40618489
Abstract
[BACKGROUND] The incidence of prostate cancer is increasing due to the aging and early diagnosis. This study aims to evaluate the influence of Gleason, stage and age on surgery and radiotherapy.
[METHODS] In a province of northern Italy were analyzed 1381 prostate cancers diagnosed between 2018 and 2022, focusing on trends in age, stage, Gleason and treatment.
[RESULTS] Over the study period, there was slight a decline in stage I (39%, 42%, 36%, 28%, 38%) and Gleason 6 (26%, 28%, 28%, 18%, 26%), along with an increase in stage IV (13%, 13%, 15%, 20%, 16%) and Gleason 8-10 (20%, 21%, 21%, 26%, and 28%). Surgery and radiation therapy remained constant at 34% and 40%, respectively. The likelihood of receiving surgery decreased in patients aged 70-79 [OR 0.35; 0.21-0.58] and 80+ [OR 0.03; 0.02-0.07] and increased in Gleason 7 [OR 1.83; 1.27-2.65] and stage II [OR 3.89; 2.74-5.51] and III [OR 9.77; 6.34-15.05]. The possibility of receiving radiotherapy increases in patients aged 70-79 [OR 2.85; 1.75-4.65] and 80+ [OR 2.11; 1.24-3.60] and in patients with Gleason 7 [OR 1.95; 1.42-2.68] and 8-10 [OR 2.95; 1.96-4.46].
[CONCLUSIONS] During the period there was a slight shift toward more aggressive prostate cancers, but treatments remained stable.
[METHODS] In a province of northern Italy were analyzed 1381 prostate cancers diagnosed between 2018 and 2022, focusing on trends in age, stage, Gleason and treatment.
[RESULTS] Over the study period, there was slight a decline in stage I (39%, 42%, 36%, 28%, 38%) and Gleason 6 (26%, 28%, 28%, 18%, 26%), along with an increase in stage IV (13%, 13%, 15%, 20%, 16%) and Gleason 8-10 (20%, 21%, 21%, 26%, and 28%). Surgery and radiation therapy remained constant at 34% and 40%, respectively. The likelihood of receiving surgery decreased in patients aged 70-79 [OR 0.35; 0.21-0.58] and 80+ [OR 0.03; 0.02-0.07] and increased in Gleason 7 [OR 1.83; 1.27-2.65] and stage II [OR 3.89; 2.74-5.51] and III [OR 9.77; 6.34-15.05]. The possibility of receiving radiotherapy increases in patients aged 70-79 [OR 2.85; 1.75-4.65] and 80+ [OR 2.11; 1.24-3.60] and in patients with Gleason 7 [OR 1.95; 1.42-2.68] and 8-10 [OR 2.95; 1.96-4.46].
[CONCLUSIONS] During the period there was a slight shift toward more aggressive prostate cancers, but treatments remained stable.
MeSH Terms
Humans; Male; Prostatic Neoplasms; Italy; Neoplasm Grading; Aged; Neoplasm Staging; Age Factors; Prostatectomy; Aged, 80 and over; Middle Aged; Retrospective Studies
같은 제1저자의 인용 많은 논문 (3)
- From Axillary Lymph Node Dissection to Sentinel Node Biopsy in Breast Cancer: A 23-Year Population-Based Large-Sample Study with Long-Term Survival Outcomes.
- Advancing Prognostic Accuracy Beyond Classical N Staging in Colorectal Cancer: An Observational Cohort Study to Define a Lymph Node Ratio Based Risk Score.
- A Population-Based Analysis of the Cancer Incidence in Individuals under 50 in a Northern Italian Province: Focusing on Regional Disparities and Public Health Implications.